42 related articles for article (PubMed ID: 30121642)
21. A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients.
Zheng T; Pang Z; Zhao Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988073
[TBL] [Abstract][Full Text] [Related]
22. Change in sonographic brightness can predict pathological response of triple-negative breast cancer to neoadjuvant chemotherapy.
Matsuda N; Kida K; Ohde S; Suzuki K; Yamauchi H; Nakamura S; Tsunoda H
Breast Cancer; 2018 Jan; 25(1):43-49. PubMed ID: 28536943
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer.
Liu YR; Jiang YZ; Xu XE; Hu X; Yu KD; Shao ZM
Clin Cancer Res; 2016 Apr; 22(7):1653-62. PubMed ID: 26813360
[TBL] [Abstract][Full Text] [Related]
24. Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value.
Jiang YZ; Liu YR; Xu XE; Jin X; Hu X; Yu KD; Shao ZM
Cancer Res; 2016 Apr; 76(8):2105-14. PubMed ID: 26921339
[TBL] [Abstract][Full Text] [Related]
25. Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer.
Asano Y; Kashiwagi S; Onoda N; Noda S; Kawajiri H; Takashima T; Ohsawa M; Kitagawa S; Hirakawa K
Ann Surg Oncol; 2016 Apr; 23(4):1104-10. PubMed ID: 26511266
[TBL] [Abstract][Full Text] [Related]
26. Roles of miRNA and lncRNA in triple-negative breast cancer.
Xu J; Wu KJ; Jia QJ; Ding XF
J Zhejiang Univ Sci B; 2020 Sept.; 21(9):673-689. PubMed ID: 32893525
[TBL] [Abstract][Full Text] [Related]
27. The long non-coding RNA landscape in triple-negative breast cancer.
Zhang W; Guan X; Tang J
Cell Prolif; 2021 Feb; 54(2):e12966. PubMed ID: 33314471
[TBL] [Abstract][Full Text] [Related]
28. The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis.
Petrelli F; Coinu A; Borgonovo K; Cabiddu M; Ghilardi M; Lonati V; Barni S
Breast Cancer Res Treat; 2014 Apr; 144(2):223-32. PubMed ID: 24557340
[TBL] [Abstract][Full Text] [Related]
29. The potential roles of lncRNA TINCR in triple negative breast cancer.
Azman AA; Siok-Fong C; Rajab NF; Md Zin RR; Ahmad Daud NN; Mohamad Hanif EA
Mol Biol Rep; 2023 Sep; 50(9):7909-7917. PubMed ID: 37442895
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer.
Kansara S; Pandey V; Lobie PE; Sethi G; Garg M; Pandey AK
Cells; 2020 Jun; 9(6):. PubMed ID: 32575858
[TBL] [Abstract][Full Text] [Related]
31. A Minimal lncRNA-mRNA Signature Predicts Sensitivity to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Wang Q; Li C; Tang P; Ji R; Chen S; Wen J
Cell Physiol Biochem; 2018; 48(6):2539-2548. PubMed ID: 30121642
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
33. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
Yagata H; Kajiura Y; Yamauchi H
Breast Cancer; 2011 Jul; 18(3):165-73. PubMed ID: 21290263
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
